Dx Biosamples, LLC is a human biospecimen contract procurement organization formed in 2010 to address the needs of pharmaceutical, biotech, diagnostics companies and academic research organizations by providing leading edge, high quality biospecimens and comprehensive associated data. Dx Biosamples is committed to helping the research community make significant advancements in the prevention, diagnosis, and treatment of diseases.We specialize in procurement of diseased and normal fresh and frozen blood; fresh, frozen and FFPE tissues; serum, plasma, urine and other biofluids. We collect biomaterials covering such disease targets as Oncology, Autoimmune and Metabolic disorders, Neurology, Kidney diseases, Pulmonology, Infectious diseases, OB/GYN and many others.We continue to expand our IRB approved network of specialty clinical sites. Our sites have large patient populations readily accessible to get quality samples in timely manner. All materials are accompanied by comprehensive clinical data and pathology reports.

ProteoGenex, Inc. is an experienced provider of well-defined and characterized biological materials and clinical information for biomedical research community. We offer access to an extensive Biorepository as well as to the exclusive custom designed human tissue-based research service, which is the company’s largest and fastest growing business segment. ProteoGenex performs tissue, blood collection for: DNA methylation studies, Gene expression analysis, Biomarkers correlative studies, Target expression and activation profiling, DNA Panels expression analysis, DNA isolation and SNP analysis, Biomarker/target expression correlation with clinical outcome data, Functional in vitro studies (signal transduction, apoptosis, drug sensitivity) using a new drug candidate. More than 1000 studies performed for global pharmaceutical, biotech companies and academic institutions. Specimens provided by ProteoGenex have been cited as part of many successful genomics and proteomics research projects.